Overview
As Director of the Supportive Care and Survivorship Center and Co-Director of the Center for Onco-Primary Care at the Duke Cancer Institute (DCI), Cheyenne Corbett, PhD has built a robust infrastructure for comprehensive psychosocial oncology and survivorship clinical care and research. Her leadership has enabled patients and families facing cancer to access high-quality services informed by best practices, emerging evidence, and patient feedback.
Dr. Corbett has developed and sustained a suite of programs—each grounded in clinical care, research, and training—including the Duke Cancer Patient Support Program, Teen and Young Adult Oncology Program, Onco-Fertility Program, Patient Navigation Program, Psychiatry and Behavioral Health, Sexual Health and Intimacy Program, and Tobacco Cessation Program. In collaboration with Medical Director Kevin Oeffinger, MD, she also leads the Survivorship Program, Clinical Cancer Genetics Program, and the Cardio-Oncology Program.
As Co-Director of the Center for Onco-Primary Care, Dr. Corbett is advancing a national model for integrating oncology and primary care across the cancer continuum. Her work emphasizes survivorship, early detection, and whole-person care, and includes initiatives such as distress screening, risk modeling, and team-based interventions that are shaping national guidelines.
In addition to her clinical and research leadership, Dr. Corbett is deeply engaged in policy advocacy. She has contributed to white papers and strategic planning around fertility preservation insurance coverage and donor-supported patient assistance funds. Her efforts span internal policy development, philanthropic strategy, and legislative engagement, with a focus on equity, sustainability, and measurable impact.
Current Appointments & Affiliations
Recent Grants
Symptom Management and Transitioning to Engagement with Post-treatment Care for Adolescent and Young Adult Cancer Survivors (AYA STEPS)
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2029Evaluating a Patient Navigation Program to Improve Therapy Management for HER2+ Metastatic Breast Cancer Patients Treated with Tucatinib
ResearchCo Investigator · Awarded by Pfizer, Inc. · 2025 - 2026Development and Pilot Testing of a Family Building Decision Support Intervention for Female Adolescent and Young Adult Cancer Survivors
ResearchCo Investigator · Awarded by American Cancer Society, Inc. · 2025 - 2026View All Grants